Scinai Immunotherapeutics Ltd.
SCNI
$1.13
-$0.14-11.02%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 989.00K | 989.00K | 1.96M | 3.08M | 6.36M |
| Total Receivables | 139.00K | 139.00K | 217.00K | 119.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 236.00K | 236.00K | 79.00K | 324.00K | 228.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 142.00K | 142.00K | 131.00K | 138.00K | 122.00K |
| Total Current Assets | 1.51M | 1.51M | 2.39M | 3.66M | 6.71M |
|
|
|||||
| Total Current Assets | 1.51M | 1.51M | 2.39M | 3.66M | 6.71M |
| Net Property, Plant & Equipment | 10.33M | 10.33M | 11.06M | 11.19M | 11.87M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 11.84M | 11.84M | 13.45M | 14.85M | 18.58M |
|
|
|||||
| Total Accounts Payable | 659.00K | 659.00K | 376.00K | 658.00K | 546.00K |
| Total Accrued Expenses | -- | -- | 781.00K | -- | 610.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 497.00K | 497.00K | 424.00K | 364.00K | 382.00K |
| Total Finance Division Other Current Liabilities | 964.00K | 964.00K | 225.00K | 650.00K | -- |
| Total Other Current Liabilities | 964.00K | 964.00K | 225.00K | 650.00K | -- |
| Total Current Liabilities | 2.12M | 2.12M | 1.81M | 1.67M | 1.54M |
|
|
|||||
| Total Current Liabilities | 2.12M | 2.12M | 1.81M | 1.67M | 1.54M |
| Long-Term Debt | 293.00K | 293.00K | 260.00K | 19.82M | 18.60M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1.57M | 1.57M | 1.40M | 640.00K | 823.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 3.00K | 3.00K | 3.00K | 3.00K | 311.00K |
| Total Liabilities | 3.98M | 3.98M | 3.47M | 22.14M | 21.27M |
|
|
|||||
| Common Stock & APIC | 125.64M | 125.64M | 123.63M | 121.27M | 119.05M |
| Retained Earnings | -121.67M | -121.67M | -117.54M | -126.82M | -120.01M |
| Treasury Stock & Other | -1.74M | -1.74M | -1.74M | -1.74M | -1.74M |
| Total Common Equity | 2.23M | 2.23M | 4.35M | -7.28M | -2.69M |
|
|
|||||
| Preferred Stock Redeemable | 5.63M | 5.63M | 5.63M | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 5.63M | 5.63M | 5.63M | -- | -- |
|
|
|||||
| Total Common Equity | 2.23M | 2.23M | 4.35M | -7.28M | -2.69M |
| Total Preferred Equity | 5.63M | 5.63M | 5.63M | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.86M | 7.86M | 9.98M | -7.28M | -2.69M |
|
|
|||||